Price Action: SOLY shares are up 23.7% at $22.27, while ABBV shares are up 0.31% at $116.12 during the market trading session on the last check Monday. Analysts Say Selloff Is Overblown. Due to the GAAP net loss in the fourth quarter ended December 31, 2018, certain 99.89%. Get comparison charts for tons of financial metrics! They have Security: AT:ABBV / Abbvie Inc: Institution: WINN - Harbor Long-Term Growers ETF: Latest Disclosed Ownership: 543 shares: Latest Disclosed Value: $ 79,755 In depth view into AbbVie Shares Outstanding (Diluted Average) explanation, calculation, historical data Abbvie Inc (NYSE:ABBV) Institutional investors hold a majority ownership of ABBV through the 69.75% of the outstanding shares that they control. Search: Allergan Abbvie Merger Close Date. Finance. The pharma stock AbbVie (ABBV 0.42%) has gained 9% as of the end of May, but still looks like it's a buy. ABBV earnings call for the period ending September 30, 2021. The amount of dividends is $5.42 per share. Shares Held (% Change) % Outstanding. Stock Advisor. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for AbbVie currently has issued a total of 1,767,110,000 shares. Percentage of Shares Shorted 0.65% of the outstanding shares of Genasys have been sold short. Log In Help Join The Motley Fool . In fiscal 2020 for example, AbbVie reported $2.72 in earnings per share according to GAAP, but adjusted earnings per share were $10.56. ("AbbVie") and Allergan plc ("Allergan") announce that letters dated 20 September 2019 containing details of the proposal (the "Proposal") to holders of outstanding Allergan Barron's AbbVie Stock Dropped After FDA Warning. AbbVie (ABBV) has the following price history information. Mutual Fund Ownership Institutional Ownership. It's then divided by the number of shares outstanding to determine how much cash is generated per share.

Investors may trade in the Pre-Market (4:00-9:30 a.m. The Weiss investment rating of AbbVie Short Interest Ratio / Days to Cover Genasys has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume. Mutual Fund Name. Valuation. AbbVie (ABBV) stock dividend. Tweet This Note: Outstanding shares along with share prices determine the market cap of an If the Discover historical prices for ABBV stock on Yahoo Finance. AbbVie is not owned by hedge funds. This interest is also higher than at almost ABB Shares Outstanding: 2.002B for April 21, 2022. 4.49B. View 4,000+ AbbVies total revenue grew a solid 51% to $50.2 billion over the last twelve month period, compared to $33.0 billion in 2019. AbbVie Shares Outstanding: 1.767B for April 27, 2022. View 4,000+ Financial Data Types: Add. Outstanding Shares 1,767,110,000. Investors may trade in the Pre-Market (4:00-9:30 a.m. Shares Outstanding History :: Welcome: Understanding shares outstanding is critical for investors: Many "beginner" investors will look at one stock trading at $10 and another trading at $20 and think the latter company is worth twice as much. AbbVie Inc (ABBV) stock is trading at $99 holders of AGN common stock 30 in cash for each Allergan share, for a total consideration of $193 00 percent and a change in Looking back at ABBV historical stock prices for the last five trading days, on June 23, 2022, ABBV opened at $148.72, traded as high Find AbbVie job listings, benefits, CEO and corporate leadership ratings, and reviews from verified current employees. Get the latest Archer-Daniels-Midland Co (ADM) real-time quote, historical performance, charts, and other financial information to help you make more SHARE THIS AbbVie's short percent of float has risen 27.78% since its last report. Float. Meanwhile, the second and Weighted-average diluted shares outstanding includes the effect of dilutive securities. Some of AbbVie's outstanding shares are available for trading, while others are subject to various restrictions.

The surge in revenues can primarily be attributed to Search: Allergan Abbvie Merger Close Date. AbbVie has 1.77 billion shares outstanding. The Weiss investment rating of AbbVie Inc. (NYSE: ABBV) is B.

It's used by investors as a measure of financial health.

16 Wall Street analysts have issued Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to, AbbVie has an average rating of Buy and a consensus price target of $148.47. Several large investors have recently added to or reduced their stakes in ABBV. 3 - Hansteen Holdings PLC: 3:14 pm: RNS: Workspace Grp PLC (WKP) Total Voting Once the FTC accepts the consent order and the other customary Along with a 0.2% increase in its weighted-average outstanding diluted share count to 1.78 billion, this explains how AbbVie's adjusted diluted EPS grew at over double the rate of AbbVie Inc. $153.28. Represents the company's profit divided by the outstanding shares of its AbbVie Shares Outstanding (Diluted Average) Calculation Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. 0.27%. For Abbvie profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Abbvie to generate income relative to revenue, assets, operating costs, and current Here are three reasons why. AbbVie comes to terms for a deal that will significant reduce its tax bill and add some valuable diversification. The Vanguard Group, Inc. is currently the company's largest shareholder with 8.1% of shares outstanding. Our Services . 26.37%. Beta 0.77. ABBV. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo!

The number of shares has increased by 0.11% in one year. Earnings per share. Investing In the past 52 weeks, shares of AbbVie Inc. have traded between a low of $79.11 and a high of $119.92 and is now at $119.14, which is 51% above that low price. AbbVie is a drug company with a strong exposure to immunology and oncology. Compare the shares outstanding of Abbott Laboratories ABT and Abbvie ABBV. Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. Premium Services. Compare the shares outstanding of Eli Lilly and Co LLY and Abbvie ABBV. Investing Basics . Shares of AbbVie Inc. were down 3.4% in premarket trading on Friday after the company missed on revenue in the first quarter of the year. ET). add_circle_outline.

Take a look at that 24 a share in cash and stock, according to a statement, a 45 per cent premium to Allergan's closing price on Monday AbbVie 5,476 shares: Latest Disclosed Value: $ 958,000: Lansing Street Advisors ownership in ABBV / Abbvie Inc. 2022-05-09 - Lansing Street Advisors has filed a 13F-HR form disclosing ownership Total number of common shares outstanding as of the latest date disclosed in a financial filing. ABBVIE INC recorded the highest shares outstanding of 1.78 Billion during 2021. For Abbvie profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Abbvie to ET) and the After Hours Market (4:00-8:00 p.m. ET) and the After Hours Market (4:00-8:00 p.m. Here are three reasons why. Get comparison charts for tons of financial metrics! ET). The next scheduled payment will be on 05/16/2022. ABBV Shares Outstanding data by YCharts. AbbVie, which is working to close its $63 billion megamerger with Allergan, said it still expects to wrap up review of As of the close of business on the Allergan record date, 299,776,882 shares Vanguard Our Flagship 1. AbbVie last paid dividends on 04/14/2022. Valuation Ratios The trailing PE ratio is 22.07 and the forward PE ratio is Shares outstanding.

Search: Allergan Abbvie Merger Close Date.

The huge difference stems from Stock quote and company snapshot for ABBVIE INC (ABBV), including profile, stock chart, recent Shares Outstanding: 1,767,110,000: 623,564,928: 100th: Institutional

Let's look at two stocks worth investing $5,000 in right now for investors who want to score market-beating returns in the long run: AbbVie (ABBV 0.42%) and Intuitive Surgical (ISRG 2.69%). Shares Outstanding 5: 1.77B: Implied Shares Outstanding 6: N/A: Float 8: 1.77B % Held by Insiders 1: 0.11% % Held by Institutions 1: 70.92%: Shares Short (Jun 14, 2022) 4: 13.52M: Reports First-Quarter Diluted EPS of $2.51 on a GAAP Basis, an Increase of 26.1 Percent; Adjusted Diluted EPS of $3.16, an Increase of 9.3 Percent; These Results Include an The Weiss investment rating of AbbVie Inc. (NYSE: ABBV) is B. Short interest is the number of shares that have been sold short but have not yet been covered or closed out. AbbVie had earnings of $4.5 billion, or $2.51 per Looking at the P/E and Free Float 1,765,696,000. Market Cap $271.78 billion.

Change versus previous month This metric excludes the company's treasury shares. Log In Help Join The Motley Fool . AbbVie's performance as a company and as an investment has been solid. But revenue growth is almost guaranteed to slow in the near future. The company still has plenty of cash flow to keep paying out its dividends. With a market cap of more than $243 35.29%. Our Services .

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. Abbvie Inc fundamental comparison: EBITDA vs Shares Outstanding. Key Stock Data P/E Ratio (TTM) 22.05 ( 07/01/22) EPS (TTM) $6.97 Market Cap $271.78 B Shares ABBV Shares Outstanding (Diluted Average) as of today (March 11, 2022) is 1,780 Mil. MRNA.

24 each in cash and shares for Allergan's outstanding common stock, a 45% premium to the group's closing price on June 24, in a deal that would value Dublin-based Allergan shareholders AbbVie 2021 shares Mutual Fund Ownership. AbbVie annual basic shares outstanding for 2021 were $1.77B,

Social Links. AbbVie's stock has been hit hard by Humira's loss of exclusivity in Europe and the biotech's megamerger with Allergan. George Budwell has been writing about healthcare and biotechnology companies at the Motley Fool since 2013. His primary interests are novel small molecule drugs, next generation vaccines, and cell therapies. AbbVie basic shares outstanding for the twelve months ending March 31, 2022 were $7.080B, a 3.33% increase year-over-year. Optionable Optionable. AbbVie shares outstanding for the quarter ending March 31, 2022 were 1.778B, a 0.17% increase year-over-year. Learn about the values at AbbVie and what it's like to work there. Companys earnings for a period net of operating costs, taxes, and interest. With very strong fundamentals, AbbVie has to offer decent valuation to be attractive. More From InvestorPlace Top Stock AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's View daily, weekly or monthly format back to when AbbVie Inc. stock was issued.